Literature DB >> 12623189

Microcrystals for dissolution rate enhancement of poorly water-soluble drugs.

Norbert Rasenack1, Helge Hartenhauer, Bernd W Müller.   

Abstract

Slight dissolution rates related to poor water-solubility are one of the well-known difficulties to be covered during the development of new drug substances. The poorly water-soluble drug ECU-01, a low molecular enzyme-inhibitor with anti-inflammatory properties for oral administration, shows a poor dissolution rate. This study is intended to enhance the drug dissolution rate by using microcrystals. The common way for micronization is the milling of previously formed larger crystals. However, milling shows several disadvantages as the newly created surfaces are thermodynamically activated due to the high energy input and not naturally grown. In this study microcrystals were not produced using any cutting up techniques, but only by association. Naturally grown microcrystals were prepared by a precipitation method in the presence of stabilizing agents (e.g. gelatin, chitosan, different types of cellulose ethers) followed by spray-drying of the formed dispersion. First the drug was dissolved in acetone and then precipitated by rapid pouring an aqueous solution of the stabilizer into the drug solution. Particularly, cellulose ethers were able to form stable and homogeneous dispersions of microcrystals (mean particle size = 1 microm) showing a tight particle size distribution. By spray-drying, the drug powder was obtained. The dissolution rate is significantly enhanced (common drug: 4% after 20 min/microcrystals 93% after 20 min) due to the large surface, which is hydrophilized by adsorbed stabilizers as shown by the decreased contact angle (65 and 30 degrees, respectively). Copyright 2003 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623189     DOI: 10.1016/s0378-5173(03)00005-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  29 in total

1.  Dissolution and solid-state characterization of poorly water-soluble drugs in the presence of a hydrophilic carrier.

Authors:  Rahmat Talukder; Chase Reed; Thomas Dürig; Muhammad Hussain
Journal:  AAPS PharmSciTech       Date:  2011-09-20       Impact factor: 3.246

2.  Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticles.

Authors:  Fahim Khan; Rajesh Katara; Suman Ramteke
Journal:  AAPS PharmSciTech       Date:  2010-09-04       Impact factor: 3.246

3.  What is a suitable dissolution method for drug nanoparticles?

Authors:  Desmond Heng; David J Cutler; Hak-Kim Chan; Jimmy Yun; Judy A Raper
Journal:  Pharm Res       Date:  2008-03-05       Impact factor: 4.200

4.  Influence of microcrystal formulation on in vivo absorption of celecoxib in rats.

Authors:  Mohamed Nasr
Journal:  AAPS PharmSciTech       Date:  2013-03-30       Impact factor: 3.246

Review 5.  An overview on in situ micronization technique - An emerging novel concept in advanced drug delivery.

Authors:  K R Vandana; Y Prasanna Raju; V Harini Chowdary; M Sushma; N Vijay Kumar
Journal:  Saudi Pharm J       Date:  2013-05-29       Impact factor: 4.330

6.  Comparative oral bioavailability advantage from curcumin formulations.

Authors:  Bhushan Munjal; Yogesh Bapurao Pawar; Sarsvatkumar Babulal Patel; Arvind Kumar Bansal
Journal:  Drug Deliv Transl Res       Date:  2011-08       Impact factor: 4.617

7.  Reversible Micro- and Nano- Phase Programming of Anthraquinone Thermochromism Using Blended Block Copolymers.

Authors:  Yumiao Zhang; Jonathan F Lovell
Journal:  Langmuir       Date:  2015-12-11       Impact factor: 3.882

8.  Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer.

Authors:  Maryam Maghsoodi; Ali Nokhodchi
Journal:  Adv Pharm Bull       Date:  2016-12-22

9.  Application of a four-fluid nozzle spray drier to prepare inhalable rifampicin-containing mannitol microparticles.

Authors:  Takuto Mizoe; Tetsuya Ozeki; Hiroaki Okada
Journal:  AAPS PharmSciTech       Date:  2008-06-18       Impact factor: 3.246

10.  Development and validation of a discriminative dissolution test for betamethasone sodium phosphate and betamethasone dipropionate intramuscular injectable suspension.

Authors:  Alice Simon; Vinícius Raphael de Almeida Borges; Lucio Mendes Cabral; Valéria Pereira de Sousa
Journal:  AAPS PharmSciTech       Date:  2013-02-01       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.